IBEX (FRA:IB7) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:IB7 IBEX Ltd FRA:IB7
78 GF Score
Price €25.80
GF Value €26.53
! 1 Warning Sign
View Full Analysis

What is IBEX Research & Development?

IBEX FRA:IB7 -1.53% 78 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:IB7 with a GF Score™ of 78/100 and a GF Value™ of €26.53. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. IBEX's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

IBEX  (FRA:IB7) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

IBEX Research & Development Related Terms

IBEX Research & Development Historical Data

* Premium members only.

The historical data trend for IBEX's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IBEX Research & Development Chart

IBEX Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IBEX Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:IB7
78GF Score
IBEX Ltd FRA:IB7
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IBEX Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
IBEX (FRA:IB7) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on IBEX and its competitors.
Is IBEX's Research & Development too high?
IBEX's current Research & Development is €0.0 Mil. Overall, IBEX has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does IBEX's Research & Development compare to TSSI and UIS?
IBEX's Research & Development of €0.0 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on IBEX and its competitors. IBEX's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IBEX stock overvalued right now?
IBEX (FRA:IB7) has a current Research & Development of €0.0 Mil. The stock's GF Value™ is €26.53, compared to a current price of €25.80 — trading 2.8% below its estimated fair value. The current Research & Development is €0.0 Mil. IBEX's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For IBEX (FRA:IB7), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IBEX (FRA:IB7) Overvalued in 2026?

Based on GuruFocus' analysis, IBEX stock appears to be undervalued. The current stock price of €25.80 is trading 2.8% below its estimated GF Value™ of €26.53.

Key valuation signals for FRA:IB7:

  • Research & Development: €0.0 Mil
  • GF Value™: €26.53 vs. price of €25.80 (2.8% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the FRA:IB7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IBEX Business Description

Other Exchanges IBEX:USAIB7:Germany
Address 1717 Pennsylvania Avenue NW, Suite 825, Washington DC, WA, USA, 20006
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
78GF Score

Get the complete analysis for FRA:IB7

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€25.80
Price
€26.53
GF Value